Dolby Laboratories, Inc. vs FMC Corp — how do they compare? Dolby Laboratories, Inc. trades at $61.2 (market cap $5.75B), while FMC Corp trades at $10.48 (market cap $1.30B). The key difference: Dolby Laboratories, Inc. is far larger — about 4.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.07%). Which is the better fit depends on your goals.
| DLB | FMC | |
|---|---|---|
Market Cap | $5.75B | $1.30B |
Sector | Industrials | Basic Materials |
52-Week High | $75.62 | $40.69 |
52-Week Low | $48.51 | $10.01 |
Enterprise Value | $5.12B | $5.11B |
Dividend Yield | 2.35% | 3.07% |
Signals from Pluang's Aura AI — not financial advice
DLB trades at $61.39, down 1.14% today, with a bullish technical signal from moving averages and a consensus analyst price target of $87.50. The company has beaten EPS estimates for the last four quarters, including Q2 2026, and maintains strong profitability with an 87.61% gross margin. Recent news highlights growth in Dolby Atmos and auto licensing, though revenue declined year-over-year in Q3 2026.
The outlook is positive with analyst support and operational strength, but risks include licensing volatility and near-term execution challenges. The stock offers upside to the price target, supported by cash flow growth and market expansion in audio-visual technologies.
FMC Corporation (FMC) trades at $10.24, down 2.1% today, reflecting ongoing investor concerns despite recent earnings beats. The stock shows a bearish technical signal with key support at $10 and resistance at $11. Fundamentally, the company faces significant challenges with a net income margin of -84.83% and negative ROE of -91.47% for 2025, though valuation ratios like P/S of 0.4 and P/B of 0.8 appear attractive. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide technology.
The outlook remains cautious due to persistent profitability issues and revenue declines, with 2025 revenue dropping to $3.47B from $4.2B in 2024. While analyst consensus is mixed with a $11.60 price target suggesting modest upside, high debt levels and competitive pressures pose substantial risks. The company's focus on debt reduction through asset sales and external investments provides some stability, but turnaround execution is critical for sustained recovery.
Trailing returns across standard periods
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.
Read more on DLB →FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →